PortfoliosLab logo
PortfoliosLab logo
Tools
Performance Analysis
Portfolio Analysis
Factor Model
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
VNDA vs. NVDY
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility

Correlation

The correlation between VNDA and NVDY is 0.02, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.


-0.50.00.51.00.0

Performance

VNDA vs. NVDY - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Vanda Pharmaceuticals Inc. (VNDA) and YieldMax NVDA Option Income Strategy ETF (NVDY). The values are adjusted to include any dividend payments, if applicable.

-20.00%-10.00%0.00%10.00%20.00%SeptemberOctoberNovemberDecember2025February
-15.52%
10.39%
VNDA
NVDY

Key characteristics

Sharpe Ratio

VNDA:

0.07

NVDY:

1.45

Sortino Ratio

VNDA:

0.77

NVDY:

1.95

Omega Ratio

VNDA:

1.08

NVDY:

1.28

Calmar Ratio

VNDA:

0.06

NVDY:

3.27

Martin Ratio

VNDA:

0.24

NVDY:

8.88

Ulcer Index

VNDA:

20.43%

NVDY:

7.79%

Daily Std Dev

VNDA:

66.58%

NVDY:

47.97%

Max Drawdown

VNDA:

-98.42%

NVDY:

-21.19%

Current Drawdown

VNDA:

-85.92%

NVDY:

-7.83%

Returns By Period

In the year-to-date period, VNDA achieves a -6.89% return, which is significantly lower than NVDY's -0.54% return.


VNDA

YTD

-6.89%

1M

2.29%

6M

-15.53%

1Y

1.83%

5Y*

-19.84%

10Y*

-9.01%

NVDY

YTD

-0.54%

1M

-1.50%

6M

10.39%

1Y

69.79%

5Y*

N/A

10Y*

N/A

*Annualized

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Risk-Adjusted Performance

VNDA vs. NVDY — Risk-Adjusted Performance Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

VNDA
The Risk-Adjusted Performance Rank of VNDA is 4949
Overall Rank
The Sharpe Ratio Rank of VNDA is 4848
Sharpe Ratio Rank
The Sortino Ratio Rank of VNDA is 5252
Sortino Ratio Rank
The Omega Ratio Rank of VNDA is 4747
Omega Ratio Rank
The Calmar Ratio Rank of VNDA is 4848
Calmar Ratio Rank
The Martin Ratio Rank of VNDA is 4848
Martin Ratio Rank

NVDY
The Risk-Adjusted Performance Rank of NVDY is 6565
Overall Rank
The Sharpe Ratio Rank of NVDY is 5858
Sharpe Ratio Rank
The Sortino Ratio Rank of NVDY is 5454
Sortino Ratio Rank
The Omega Ratio Rank of NVDY is 6161
Omega Ratio Rank
The Calmar Ratio Rank of NVDY is 8585
Calmar Ratio Rank
The Martin Ratio Rank of NVDY is 7070
Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

VNDA vs. NVDY - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for Vanda Pharmaceuticals Inc. (VNDA) and YieldMax NVDA Option Income Strategy ETF (NVDY). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


Sharpe ratio
The chart of Sharpe ratio for VNDA, currently valued at 0.07, compared to the broader market-2.000.002.004.000.071.45
The chart of Sortino ratio for VNDA, currently valued at 0.77, compared to the broader market-6.00-4.00-2.000.002.004.006.000.771.95
The chart of Omega ratio for VNDA, currently valued at 1.08, compared to the broader market0.501.001.502.001.081.28
The chart of Calmar ratio for VNDA, currently valued at 0.11, compared to the broader market0.002.004.006.000.113.27
The chart of Martin ratio for VNDA, currently valued at 0.24, compared to the broader market0.0010.0020.0030.000.248.88
VNDA
NVDY

The current VNDA Sharpe Ratio is 0.07, which is lower than the NVDY Sharpe Ratio of 1.45. The chart below compares the historical Sharpe Ratios of VNDA and NVDY, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Rolling 12-month Sharpe Ratio0.001.002.003.004.00SeptemberOctoberNovemberDecember2025February
0.07
1.45
VNDA
NVDY

Dividends

VNDA vs. NVDY - Dividend Comparison

VNDA has not paid dividends to shareholders, while NVDY's dividend yield for the trailing twelve months is around 89.19%.


TTM20242023
VNDA
Vanda Pharmaceuticals Inc.
0.00%0.00%0.00%
NVDY
YieldMax NVDA Option Income Strategy ETF
89.19%83.65%22.32%

Drawdowns

VNDA vs. NVDY - Drawdown Comparison

The maximum VNDA drawdown since its inception was -98.42%, which is greater than NVDY's maximum drawdown of -21.19%. Use the drawdown chart below to compare losses from any high point for VNDA and NVDY. For additional features, visit the drawdowns tool.


-40.00%-30.00%-20.00%-10.00%0.00%SeptemberOctoberNovemberDecember2025February
-33.03%
-7.83%
VNDA
NVDY

Volatility

VNDA vs. NVDY - Volatility Comparison

The current volatility for Vanda Pharmaceuticals Inc. (VNDA) is 12.53%, while YieldMax NVDA Option Income Strategy ETF (NVDY) has a volatility of 22.75%. This indicates that VNDA experiences smaller price fluctuations and is considered to be less risky than NVDY based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


10.00%15.00%20.00%SeptemberOctoberNovemberDecember2025February
12.53%
22.75%
VNDA
NVDY
PortfoliosLab logo
Performance Analysis
Portfolio AnalysisPortfolio PerformanceStock ComparisonSharpe RatioMartin RatioTreynor RatioSortino RatioOmega RatioCalmar RatioSummers Ratio
Community
Discussions


Disclaimer

The information contained herein does not constitute investment advice and made available for educational purposes only. Prices and returns on equities are listed without consideration of fees, commissions, taxes, penalties, or interest payable due to purchasing, holding, or selling.

Copyright © 2025 PortfoliosLab